Status:
TERMINATED
Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities
Lead Sponsor:
Rijnstate Hospital
Collaborating Sponsors:
Kimberly-Clark Corporation
Conditions:
Arterial Obstructive Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to prove a reduction of postoperative wound infections after direct preoperative use of a microbial sealant in the form of Integuseal for vascular procedures on lower extr...
Eligibility Criteria
Inclusion
- planned supragenual of infragenual peripheral arterial bypass procedures with autologue or prosthetic graft
Exclusion
- secondary procedures and suprainguinal procedures
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00940979
Start Date
January 1 2010
End Date
May 1 2011
Last Update
January 13 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Rijnstate
Arnhem, Netherlands, 6800 TA
2
Ziekenhuis Slingland
Doetinchem, Netherlands
3
Ziekenhuis Nij Smellinghe
Drachten, Netherlands